Question

Which of the following are advantages/benefits of non-treponemal tests (e.g., VDRL, RPR) in the diagnosis and follow-up of syphilis? (Select all that apply)

• A. They can be used to monitor response to treatment
• B. A standard dilution is used
• C. They remain positive for life
• D. They are quantitative

Hint:

Titre-based = quantitative, so they track treatment response.

Answer 1

The Correct Option is A

Step 1: Recall non-treponemal tests.
Non-treponemal tests (VDRL, RPR) detect antibodies against cardiolipin-lecithin-cholesterol antigen. Their titres rise and fall with disease activity, unlike treponemal tests which usually stay positive for life.

Step 2: Evaluate each statement.
(A) Response to treatment - CORRECT. A four-fold (two-dilution) drop in titre indicates successful therapy, and a four-fold rise indicates relapse/re-infection. This monitoring ability is the principal advantage.
(B) Standard dilution - not an advantage; non-treponemal tests are reported as serial dilutions/titres (1:2, 1:4, 1:8 …), not a single standard dilution.
(C) Lifetime positivity - this is a feature of treponemal tests, not non-treponemal ones; non-treponemal titres decline/revert after treatment, so this is not their benefit.
(D) Quantitative - CORRECT. Because results are expressed as titres, the test is quantitative, which is precisely what enables treatment monitoring.

Step 3: Conclusion.
The benefits are that the tests are quantitative and therefore allow monitoring of response to treatment (options A and D). The primary single best answer is response to treatment, which directly derives from the quantitative titre.

Key fact: Non-treponemal tests are quantitative (titre-based), letting you monitor treatment response; treponemal tests, by contrast, stay positive for life.